Table 2.

Percentage of apoptotic cells obtained in A549 lung, SKVO3 ovary and MCF7 breast cancer cells treated with 50 nm original docetaxel and novel docetaxel analogue (CQMU‐0519)

	LL (Live cells %)	LR (Early apoptotic cells %)	UR (Late apoptotic cells %)	UL (Necrotic cells %)
A549 lung control	98.99	1.00	0.01	0.00
Original docetaxel	61.90	9.31	22.27	2.92
CQMU‐0519	21.43	2.10	59.11	17.37
SKVO3 ovary control	99.15	0.05	0.04	0.76
Original docetaxel	86.40	2.71	3.09	7.80
CQMU‐0519	83.31	7.9	3.43	5.36
MCF7 breast control	99.85	0.15	0.00	0.00
Original docetaxel	73.59	2.03	19.92	4.46
CQMU‐0519	53.53	35.57	9.48	1.42